ACI
ICPT

Alpha Cubed Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Alpha Cubed Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,590
Closed -$376K – 162
2014
Q3 		$376K Sell
1,590
-1,255
-44% -$320K 0.18% 111
2014
Q2 		$673K Buy
+2,845
New +$750K 0.3% 98

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alpha Cubed Investments's ICPT Position: Q4 2014 in Review

Alpha Cubed Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2014, closing a stake of 1,590 shares — an estimated $376K sold.

Alpha Cubed Investments first reported a position in ICPT in Q2 2014 and held it in 2 quarters. The position peaked at $673K in Q2 2014. 169 funds tracked by Wall St. Rank hold ICPT as of Q4 2014.

  • Alpha Cubed Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Alpha Cubed Investments sold 1,590 Intercept Pharmaceuticals, Inc. shares in Q4 2014, an estimated $376K.
  • Alpha Cubed Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • Alpha Cubed Investments's Intercept Pharmaceuticals, Inc. position peaked at $673K in Q2 2014.
  • 169 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2014.

Based on Alpha Cubed Investments's 13F filing for Q4 2014, filed 30 Jan 2015.